Tradeshift

Tradeshift – Private Placement: 75 mUSD

75 million USD is the amount Tofte & Company managed to raise in a private placement for TradeShift in February 2014.

We are proud to be part of this transaction, and we are proud to be the preferred transaction advisory to TradeShift.

AirHelp2

AirHelp – Private Placement from Business Angels: 0.4 mUSD

A group of business angels from the Tofte & Company network, have invested 400,000 USD in AirHelp

The first transaction so far for AirHelp, but most likely not the last! Tofte & Company have been with these guys from the very beginning, and we are excited to see the interest from so many business angels already. The private placement of 400,000 USD was sourced through the extensive network within Tofte & Company. We are looking forward to see where these guys will go, and we are proud to be their preferred deal partner during their journey.

BioPorto1

BioPorto Diagnostics – Public Rights Issue: 12 mUSD

Public Rights Issue of 12 million USD to BioPorto Diagnostics.

Tofte & Company has been involved in this transaction from day one, and we are proud to say so!

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Their pioneering product portfolio includes assays for underserved disease states such as NGAL for acute kidney injury. They sell our products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the NASDAQ OMX Copenhagen stock exchange.